RU2009113712A - APPLICATION OF ORGANIC DYES AS ANESTHETIC MEDICINES - Google Patents
APPLICATION OF ORGANIC DYES AS ANESTHETIC MEDICINES Download PDFInfo
- Publication number
- RU2009113712A RU2009113712A RU2009113712/15A RU2009113712A RU2009113712A RU 2009113712 A RU2009113712 A RU 2009113712A RU 2009113712/15 A RU2009113712/15 A RU 2009113712/15A RU 2009113712 A RU2009113712 A RU 2009113712A RU 2009113712 A RU2009113712 A RU 2009113712A
- Authority
- RU
- Russia
- Prior art keywords
- use according
- agent
- solution
- administered
- tumor
- Prior art date
Links
- 230000003444 anaesthetic effect Effects 0.000 title claims abstract 3
- 239000003814 drug Substances 0.000 title claims abstract 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract 10
- 206010028980 Neoplasm Diseases 0.000 claims abstract 4
- 239000007864 aqueous solution Substances 0.000 claims abstract 4
- 239000000243 solution Substances 0.000 claims abstract 4
- 206010058019 Cancer Pain Diseases 0.000 claims abstract 2
- 206010027476 Metastases Diseases 0.000 claims abstract 2
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 claims abstract 2
- 239000013078 crystal Substances 0.000 claims abstract 2
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 229960001235 gentian violet Drugs 0.000 claims abstract 2
- 229940002712 malachite green oxalate Drugs 0.000 claims abstract 2
- 235000012054 meals Nutrition 0.000 claims abstract 2
- 230000009401 metastasis Effects 0.000 claims abstract 2
- 239000002674 ointment Substances 0.000 claims abstract 2
- 239000000829 suppository Substances 0.000 claims abstract 2
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Применение органического красителя из группы: кристаллвиолет, генцианвиолет, малахитовый зеленый оксалат и родамин 6Ж, в качестве обезболивающего средства, в виде раствора с дозировкой средства от 0,000001 мг до 10 г на прием. ! 2. Применение по п.1, отличающееся тем, что средство принимают не менее двух раз в день. ! 3. Применение по любому из пп.1 и 2, отличающееся тем, что средство вводят перорально в виде водного раствора. ! 4. Применение по п.3, отличающееся тем, что средство принимают до или после еды. ! 5. Применение по любому из пп.1 и 2, отличающееся тем, что средство вводят ректально в виде водного раствора. ! 6. Применение по любому из пп.1 и 2, отличающееся тем, что 1% раствор средства вводят внутривенно. ! 7. Применение по любому из пп.1 и 2, отличающееся тем, что применяют средство в виде 1-5% мази. ! 8. Применение по любому из пп.1 и 2, отличающееся тем, что средство вводят ректально в виде свечей. ! 9. Применение по любому из пп.1 и 2, отличающееся тем, что при купировании онкологических болей средство вводят инъекционно в опухоль (под опухоль) или в метастаз. 1. The use of organic dye from the group: crystal violet, gentian violet, malachite green oxalate and rhodamine 6G, as an anesthetic, in the form of a solution with a dosage of from 0.000001 mg to 10 g per dose. ! 2. The use according to claim 1, characterized in that the tool is taken at least twice a day. ! 3. The use according to any one of claims 1 and 2, characterized in that the agent is administered orally in the form of an aqueous solution. ! 4. The use according to claim 3, characterized in that the tool is taken before or after a meal. ! 5. The use according to any one of claims 1 and 2, characterized in that the agent is administered rectally in the form of an aqueous solution. ! 6. The use according to any one of claims 1 and 2, characterized in that a 1% solution of the drug is administered intravenously. ! 7. The use according to any one of claims 1 and 2, characterized in that the agent is used in the form of 1-5% ointment. ! 8. The use according to any one of claims 1 and 2, characterized in that the agent is administered rectally in the form of suppositories. ! 9. The use according to any one of claims 1 and 2, characterized in that when stopping cancer pain, the agent is injected into the tumor (under the tumor) or into metastasis.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009113712/15A RU2009113712A (en) | 2009-04-14 | 2009-04-14 | APPLICATION OF ORGANIC DYES AS ANESTHETIC MEDICINES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009113712/15A RU2009113712A (en) | 2009-04-14 | 2009-04-14 | APPLICATION OF ORGANIC DYES AS ANESTHETIC MEDICINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009113712A true RU2009113712A (en) | 2010-10-20 |
Family
ID=44023646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009113712/15A RU2009113712A (en) | 2009-04-14 | 2009-04-14 | APPLICATION OF ORGANIC DYES AS ANESTHETIC MEDICINES |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2009113712A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12070570B2 (en) | 2015-04-30 | 2024-08-27 | Safe Iv Ltd. | Injectables |
-
2009
- 2009-04-14 RU RU2009113712/15A patent/RU2009113712A/en not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12070570B2 (en) | 2015-04-30 | 2024-08-27 | Safe Iv Ltd. | Injectables |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021000622A1 (en) | Use of niclosamide for the preparation of a medicament for the treatment of autoimmune colitis, an inflammatory bowel disease, iatrogenic autoimmune colitis, divisional of patent application No. 559-2018. | |
| PE20210667A1 (en) | BENZAMIDE DERIVATIVES FOR INHIBITION OF ABL1, ABL2 AND BCR-ABL1 ACTIVITY | |
| BRPI0821301B8 (en) | isosorbide aspirinate compound, pharmaceutical composition, and its use | |
| AR109590A2 (en) | POSTOLOGICAL REGIME FOR COMT INHIBITORS | |
| BR112015026006A8 (en) | compound in combination with an imid® immunomodulatory drug, pharmaceutical composition comprising them, use of the same and kit | |
| CO6540003A2 (en) | BENZODIAZEPINA BROMODOMINIUM INHIBITOR | |
| ECSP034567A (en) | SPIROPIRIMIDIN-2,4,6-TRIONA METALOPROTEINASE INHIBITORS | |
| CO2025007341A2 (en) | nlrp3 inflammasome inhibitor and its use | |
| AR096892A1 (en) | A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA | |
| RU2015134581A (en) | NITROXIL DONORS WITH IMPROVED THERAPEUTIC INDEX | |
| AR025885A1 (en) | DERIVATIVES OF INDOLIL-3-GLIOXILIC ACID WITH VALUABLE THERAPEUTIC PROPERTIES | |
| AR097619A1 (en) | USE OF ACETIL-COA CARBOXYLASE INHIBITORS TO TREAT ACNÉ VULGARIS | |
| AR115913A1 (en) | BIO AVAILABLE ORAL DOSAGE FORMS, USE, METHODS | |
| MX2019014675A (en) | Levodopa infusion solution. | |
| UY39288A (en) | PHARMACEUTICAL FORMS OF ACALABRUTINIB MALEATE | |
| ES2563068T3 (en) | Multiple sclerosis (MS) treatment with Campath-1H | |
| RU2009113712A (en) | APPLICATION OF ORGANIC DYES AS ANESTHETIC MEDICINES | |
| UY31826A (en) | PEPTIDE COMPOUND AND ITS USE | |
| ATE410152T1 (en) | THERAPEUTIC SYSTEM WITH AMOXICILLIN AND CLAVULANIC ACID | |
| PE20130782A1 (en) | PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME | |
| AR111803A1 (en) | DERIVED FROM CICLOPENTAN [G] QUINAZOLIN-4-ONA AND ITS EMPLOYMENT IN THE TREATMENT OF CANCER RESISTANT TO PLATINUM | |
| RU2012100621A (en) | COMPOSITION FOR INJECTION CONTAINING HYDROXYCHLOROCHINE FOR LOCAL USE IN THE TREATMENT OF HEMORRHOIDS | |
| TN2016000179A1 (en) | Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor. | |
| CO2022014853A2 (en) | Novel compound [2-(dimethylamino)-2-phenylbutyl]-3,4,5-trimethoxybenzoate 4-methyl-2h-chromen-2-on-7-yl sulfate and use thereof | |
| HRP20171299T1 (en) | PEPTID COMBINATIONS WITH CYCLIZED FRAME |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20120415 |